NEW YORK (AP) – The federal securities fraud trial of former pharmaceutical CEO Martin Shkreli (SHKREL’-ee) is shifting towards the choice-making part.
Jurors might begin deliberating Monday on the trial in New York.
On Friday, they heard closing arguments by prosecutors accusing Shkreli of looting his personal drug firm to pay again disgruntled buyers in two failed hedge funds he ran.
The protection insisted there have been no victims as a result of everybody acquired their unique investments again and even made hefty income.
The 34-yr-previous Shkreli is greatest recognized for jacking up the worth of a life-saving drug by 5,000 % and for trolling his critics on-line.
Copyright 2017 The Related Press. All rights reserved. This materials will not be revealed, broadcast, rewritten or redistributed.